Insulins

Insulin glargine 100 IU/ml, presented as a 3 ml cartridge under the brand name Lantus SoloStar®, is a long-acting medication used to treat type 1 and type 2 diabetes mellitus. Product Description Active Ingredient: Insulin glargine (human insulin analogue, produced by recombinant DNA technology). Concentration: 100 International Units (IU) per milliliter. The 3 ml cartridge contains a total of 300 units. Brand: Lantus (Sanofi-Aventis). Presentation: It is a pre-filled, disposable device (pen) ready for use, known as SoloStar. Use: Administered by subcutaneous injection (under the skin). Use and Indications Function: Helps regulate blood glucose (sugar) levels, providing a steady, peak-free insulin level for approximately 24 hours. Indications: Treatment of diabetes mellitus in adults, adolescents, and children 2 years of age and older. Administration: Generally, one injection is given daily, always at the same time, to maintain consistent control. Important Considerations Prescription Required: Sale and use require a prescription and supervision by a healthcare professional. Do Not Share: Each pen/device is for single-patient use only to prevent the transmission of infectious diseases. Injection Site Rotation: It is essential to alternate injection sites (abdomen, thigh, buttock, or upper arm) to avoid skin changes such as lipodystrophy (thickening or lumps). Storage: Unopened: Must be refrigerated between 2°C and 8°C. Do not freeze. In Use: Can be stored at room temperature (below 30°C) for up to 4 weeks. Do not refrigerate the pen while in use. Hypoglycemia: The most common side effect is low blood sugar (hypoglycemia), which can be serious. Always carry a source of fast-acting sugar (such as glucose candy or juice). Do Not Mix: Do not dilute or mix with other types of insulin or solutions, as this may alter its action profile. This content is for informational purposes only. For medical advice or diagnosis, consult a healthcare professional. LANTUS SOLOSTAR 100 UNITS/ML PACKAGE LEAFLET ... - CIMA - aemps .:: CIMA ::. LANTUS SOLOSTAR 100 UNITS/ML PACKAGE LEAFLET INJECTION SOLUTION IN PRE-FILLED PEN. ... * What is Lantus and what is it used for? ... Page icon Spanish Agency for Medicines and Health Products Insulin glargine. Trade name: Lantus

Metformin helps control blood sugar levels in several ways, including helping the body respond better to the insulin it naturally produces and reducing the amount of sugar the liver produces and the intestines absorb from food.

Glibenclamide is a drug used in some types of diabetes in which there is no normal insulin secretion. Insulin is responsible for controlling the level of sugar (glucose) in the blood. Mechanism of action Glibenclamide Stimulates insulin secretion by ß cells of the pancreas. Reduces hepatic glucose production and increases the binding and response capacity of insulin in peripheral tissues. Therapeutic indications Glibenclamide Type II diabetes mellitus when it cannot be controlled by diet, physical exercise and weight loss. Adjuvant to insulin in insulin-dependent diabetes.

Insulin glargine 100 IU/ml injection (10 ml) is a long-acting (basal) synthetic insulin used to control high blood sugar levels in people with diabetes mellitus. Key features Active ingredient: Insulin glargine. Concentration: 100 International Units (IU) per milliliter (U-100). One 10 ml vial contains a total of 1000 units. Insulin type: Long-acting, also known as basal insulin. It provides a steady, peak-free concentration profile with a duration of action of approximately 18 to 24 hours. Presentation: Injectable solution in a 10 ml vial. Indications It is used to improve glycemic control in: Adults and children over 2 years of age with type 1 diabetes mellitus (always in combination with shorter-acting/rapid-acting mealtime insulin). Adults with type 2 diabetes mellitus. Not used to treat diabetic ketoacidosis. Administration and Dosage Route of administration: Subcutaneous (under the skin). Frequency: Usually injected once a day, at the same time every day. Injection site: The injection site should be rotated with each dose (e.g., abdomen, thigh, buttock, or upper arm) to reduce the risk of skin problems such as lipodystrophy (thickening or lumps in the skin). Dosage: The dose should be individualized and adjusted by a physician according to the patient's needs and blood glucose levels. Most common side effect The most frequent adverse reaction is hypoglycemia (low blood sugar), which can occur if the insulin dose is too high relative to the patient's needs. Common brand names Some brand names containing insulin glargine 100 IU/ml are Lantus® and Glaritus®. Important note: This medication should be used under strict medical supervision. Always follow your healthcare professional's instructions regarding dosage, timing of administration, and proper use of insulin syringes. This content is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may contain errors. Learn more undefined undefined undefined 14 sites Learn how to inject | Lantus® (insulin glargine injection) 100 ... Translated — What is Lantus® (insulin glargine injection) 100 Units/mL? Prescription LANTUS is a long-acting synthetic insulin ... Page icon Lantus Drug details: Insulin-glargine - Pediamécum Jan 14, 2021 — Insulin glargine is a long-acting human insulin analogue, produced using DNA technology.